A Blueprint for Transitioning Pharmacy Residents Into Successful Clinical Faculty Members in Colleges and Schools of Pharmacy

Por Wanat, Matthew A., Garey, Kevin W.
Publicado em 2013

Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia

Por Pai, Manjunath P., Turpin, Robin S., Garey, Kevin W.
Publicado em 2007

Antibiotic Utilization and Antimicrobial Stewardship in Community Hospitals

Por Thabit, Abrar, Shea, Katherine, Guzman, Oscar, Garey, Kevin W
Publicado no Open Forum Infect Dis (2017)

Future Novel Therapeutic Agents for Clostridium difficile Infection

Por Koo, Hoonmo L., Garey, Kevin W., DuPont, Herbert L.
Publicado em 2010

Inhibition of Biofilm Formation by Esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus

Por Singh, Vandana, Arora, Vaneet, Alam, M. Jahangir, Garey, Kevin W.
Publicado em 2012

1673 Microbial and Inflammatory Markers for Fatal Clostridium difficile Associated Diarrhea

Por Jiang, Zhi-Dong, Garey, Kevin W., Lasco, Todd M., Dupont, Herbert
Publicado no Open Forum Infect Dis (2014)

Education, Training, and Academic Experience of Newly Hired, First-Time Pharmacy Faculty Members

Por Wanat, Matthew A., Fleming, Marc L., Fernandez, Julianna M., Garey, Kevin W.
Publicado em 2014

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS

Por Patel, Twisha S, Crutchley, Rustin D, Tucker, Anne M, Cottreau, Jessica, Garey, Kevin W
Publicado em 2013

Innate Inflammatory Response and Immunopharmacologic Activity of Micafungin, Caspofungin, and Voriconazole against Wild-Type and FKS Mutant Candida glabrata Isolates

Por Beyda, Nicholas D., Liao, Guangling, Endres, Bradley T., Lewis, Russell E., Garey, Kevin W.
Publicado no Antimicrob Agents Chemother (2015)

Use of Rifamycin Drugs and Development of Infection by Rifamycin-Resistant Strains of Clostridium difficile

Por Huang, Jamie S., Jiang, Zhi-Dong, Garey, Kevin W., Lasco, Todd, DuPont, Herbert L.
Publicado em 2013

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin

Por Thabit, Abrar K., Alam, M. Jahangir, Khaleduzzaman, Mohammed, Garey, Kevin W., Nicolau, David P.
Publicado no Ann Clin Microbiol Antimicrob (2016)

Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes

Por Endres, Bradley T., Bassères, Eugénie, Khaleduzzaman, Mohammed, Alam, M. Jahangir, Chesnel, Laurent, Garey, Kevin W.
Publicado no Antimicrob Agents Chemother (2016)

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Por Endres, Bradley, Bassères, Eugénie, Rashid, Tasnuva, Chang, Long, Alam, M. Jahangir, Garey, Kevin W
Publicado no J Vis Exp (2017)

Lack of Effect of Zafirlukast on the Pharmacokinetics of Azithromycin, Clarithromycin, and 14-Hydroxyclarithromycin in Healthy Volunteers

Por Garey, Kevin W., Peloquin, Charles A., Godo, Paul G., Nafziger, Anne N., Amsden, Guy W.
Publicado em 1999

Bactericidal Activity and Postantibiotic Effect of Levofloxacin against Anaerobes

Por Pendland, Susan L., Diaz-Linares, Mariela, Garey, Kevin W., Woodward, Jennifer G., Ryu, Seonyoung, Danziger, Larry H.
Publicado em 1999

Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes

Por Tam, Vincent H., Rogers, Cary A., Chang, Kai-Tai, Weston, Jaye S., Caeiro, Juan-Pablo, Garey, Kevin W.
Publicado em 2010

Mathematical Modeling To Characterize the Inoculum Effect

Por Bhagunde, Pratik, Chang, Kai-Tai, Singh, Renu, Singh, Vandana, Garey, Kevin W., Nikolaou, Michael, Tam, Vincent H.
Publicado em 2010

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection

Por Bassères, Eugénie, Endres, Bradley T., Khaleduzzaman, Mohammed, Miraftabi, Faranak, Alam, M. Jahangir, Vickers, Richard J., Garey, Kevin W.
Publicado no J Antimicrob Chemother (2016)

Ribotypes Matter, Significance of Clostridium difficile Ribotypes in Cancer Patients with Diarrhea

Por Guevara, Eduardo Yepez, Yalamanchili, Harika, Chao, Andrew, Garey, Kevin, Bhatti, Micah, Aitken, Samuel L, Okhuysen, Pablo C
Publicado no Open Forum Infect Dis (2017)

Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia

Por Shah, Dhara N., Yau, Raymond, Lasco, Todd M., Weston, Jaye, Salazar, Miguel, Palmer, Hannah R., Garey, Kevin W.
Publicado em 2012